Bio-based organic ammonium fertilizer production using hyper-ammonia-producing bacteria

Technology
Conceptual
University

A patented bio-ammonification technology that uses hyper-ammonia-producing (HAP) bacteria to convert organic feedstocks into plant-available liquid ammoniacal nitrogen. Designed for organic vegetable and grain producers seeking precision liquid fertility, with planned scale-up from 54-liter bench capacity to commercial bioreactor volumes.

Overview

This project advances a patented method for producing organically derived ammonia and ammonium fertilizer using hyper-ammonia-producing (HAP) bacteria. The technology addresses a critical gap in organic agriculture: the limited availability of liquid nitrogen fertility options beyond traditional fish emulsions and soy-based products. By delivering ammoniacal nitrogen in liquid form directly to the plant rhizosphere, the solution enables precision fertility applications timed to crop demand. The work targets commercial-scale production of organic ammonium suitable for organic vegetable and grain operations.

Technical specifications
  • Core technology: Anaerobic fermentation and distillation process using HAP bacteria, covered under US Patent 9,868,963 B2
  • Feedstock flexibility: Designed to process protein substrates from various vegetable-based feedstocks and saccharides from lignocellulosic hydrolysates
  • Scale-up pathway: Two-phase scale-up from 54-liter bench capacity to 100–1,000 gallon commercial bioreactor, then to 10,000 gallon production capacity with approximately 96-hour cycle times for organic feedstocks
  • Modeling approach: Mathematical simulation of bio-ammonification performance across different protein substrates and concentration levels to optimize kinetics and process efficiency
  • Validation scope: Evaluation of HAP bacteria growth and ammonia/ammonium output under varying substrate concentrations, with bioprocess software simulation to predict commercial-scale performance
Technology readiness level

The technology is at an early-to-mid commercial development stage. Bench-scale validation at 54-liter capacity has been completed, and industry interest has been confirmed. Current efforts focus on maturing the reaction kinetics and conducting pilot-scale experiments before scaling to 100–1,000 gallon and ultimately 10,000 gallon bioreactor capacity. Pilot validation and bioprocess simulation studies are underway to de-risk the transition to commercial production.


About Clemson University

Clemson University is a comprehensive public land‑grant research university in Upstate South Carolina with a main campus and statewide outreach. Industry engages through co‑located facilities: an automotive innovation campus in Greenville, an energy testing complex in Charleston, and a research and technology park near the main campus with labs and offices. A strong co‑op program and corporate engagement team connect companies with faculty expertise and student talent, while the Extension network supports field trials and regional pilots. Research is backed by competitive federal funding from agencies such as NSF, NIH, DOE, USDA, and DOD. A dedicated technology transfer office provides IP, licensing, and startup support with clear pathways for industry‑sponsored agreements.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.